Novan to Participate in JMP Securities Life Sciences Conference

MORRISVILLE, N.C., June 13, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ: NOVN) today announced that it will participate in the 2019 JMP Securities Life Sciences Conference in New York on Thursday, June 20, 2019. Participation will include a fireside chat as well as a Q&A session. The company will also have a number of one-on-one meetings with investors during the conference.

The fireside chat will occur on June 20, 2019 at 9:30 a.m. Eastern. The presentation will be webcast live and can be accessed through the Investors section of the Company's website at www.Novan.com. An archived version of the webcast will be available approximately two hours following the live presentation for 7 days.

About Novan

Novan, Inc. is a clinical development-stage biotechnology company focused on leveraging nitric oxide’s naturally occurring anti-microbial and immunomodulatory mechanisms of action to treat a range of diseases with significant unmet needs. We believe that our ability to deploy nitric oxide in a solid form, on demand and in localized formulations allows us the potential to improve patient outcomes in a variety of dermatological, women’s health and gastrointestinal diseases.

CONTACT:

(Investors & Media)Cole IkkalaDirector, Investor Relations, Communications & Business Development[email protected]

You May Also Be Interested In

• Global Real Assets Trust Reports Q2 2026 Results
• Nominations Open for 40 Under 40 in Chemicals, Presented by The Chemical Summit
• Aton Closes CAD$4 Million Private Placement